INTRODUCTION
Norrie Disease (OMIM 310600; ND) is an X-linked, recessive neurological disorder that presents with congenital blindness, progressive deafness and mental retardation 1 , and is caused by mutations in the Norrie disease pseudoglioma (NDP) gene 2, 3, 4 . The high phenotypic variability even within one family carrying the same mutation 5, 6, 7 suggests the involvement of modifier genes or other factors, which might explain why no clear genotype-phenotype correlation has been described so far. In addition, mutations in this gene have also been associated with a variety of other recessive and sporadic vitreoretinal diseases, including exudative vitreoretinopathy (OMIM 133780; EVR), retinopathy of prematurity (ROP, stages 4b and 5) and Coats' disease (OMIM 300216) 8, 9, 10, 11 . These allelic clinical entities show remarkable similarities in their ocular phenotype especially with regard to abnormalities in the retinal vasculature.
The human disease phenotype is strongly resembled by the Norrie disease pseudoglioma homolog (Ndph) knockout mouse 12, 13 . Although the retinal vasculature in humans develops around mid-gestation, and only postnatally in mice, the timing of events is comparable. In mice, retinal blood vessels start to develop around birth at the optic disc and spread radially inside the nerve fiber layer across the retina, until they reach the periphery around postnatal day 9 (p9). In addition, vessels start to sprout into the deeper layers of the retina at p7 to form two additional networks in the plexiform layers, parallel to the superficial plexus. Contrary to the development of the retinal vasculature, the hyaloid vessel system, a transient developmental vasculature nourishing the developing lens, regresses. This process starts after its peak extension around p5 and lasts until p15, around which time the mice open their eyes and eye development is more or less complete 14 . In the Ndph knockout mouse, the inner retinal vessel development is severely impaired. The outgrowth of the superficial retinal vessel plexus is delayed and remains sparse, deep retinal vessels do not develop, and the regression of the hyaloid vasculature is delayed and incomplete. Furthermore, disorganization of the retinal ganglion cell layer and a reduction of retinal ganglion cells have been described 12, 15, 13 . However, proliferation of fibrovascular material in the vitreous cavity is not as massive as the pseudoglioma described in patients suffering from severe ND.
Different hypotheses have been postulated about the etiology of these symptoms. It has been discussed that the extended presence of hyaloid vessels might impair the development of the retinal vasculature 16, 17 . However, blockage of the placental growth factor (PlGF) during early postnatal stages in the eye leads to delayed regression of the hyaloid vessel system, but not to changes in the retinal vasculature 18 , indicating that persistence of the hyaloidea does not necessarily lead to defects in or lack of retinal vascularization. Another hypothesis was provided by a detailed analysis of the early development of the retinal vasculature in Ndph knockout mice, which suggested two phases of disease progression in vivo 15 : In the early phase, the absence of functional Norrin (Ndph-protein) causes a defect in sprouting angiogenesis, which leads to a delayed outgrowth of the superficial vessels and prevents the formation of deep capillary networks in the retina. Then, in the later phase, the developmental lack of the deep vasculature leads to inner retinal hypoxia. This pathologic hypoxia may explain the observed clinical features of Norrie disease and might also be responsible for the similarities of the clinical phenotypes of the aforementioned diseases 15 . In another study, the knockout phenotype could be rescued by ectopic overexpression of Norrin in the lens 19 . Their authors suggested a direct effect of Norrin on vascular proliferation, since proliferation of microvascular endothelial cells was increased after co-cultivation with the Norrin-expressing lenses 19 . 23 . This pathway eventually leads to transcriptional regulation of target genes under the control of TCF/Lef-binding sites. In summary, these data suggest that Norrin has an influence on transcriptional regulation of Wnt-target genes, is required for early angiogenic sprouting in the retina and the regression of the hyaloid vessel system, and is necessary for the formation of deep retinal capillary networks around postnatal day 7 (p7) 15 .
The main purpose of the experiment reported here was to find differently expressed genes in retinae of p7 Ndph knockout mice that are involved in the process of deep plexus formation and that could confirm Norrin's hypothesized role on Wnt target genes in vivo. Our findings support a role of Norrin in blood vessel development and provide evidence for a potential regulation of new target genes that were not considered so far. However, involvement of the Wnt/beta-catenin pathway could not be demonstrated by our experiments. One gene, the plasmalemma vesicle associated protein (Plvap), has been characterized in more detail. This gene was described as a major structural component of fenestrated blood vessels 24 , and here was found to be up-regulated in the retinal vasculature in the absence of Norrin. Thus, we discuss the question whether or not Norrin could also be involved in blood vessel integrity and the formation or maintenance of the blood-retina-/blood-brain-barrier.
MATERIALS AND METHODS

Animals
The Ndph knockout mouse line has been described before by Berger et al. 12 . Briefly, exon 2 of the Ndph gene has partially been replaced by homologous recombination with a reverse oriented neomycin cassette, resulting in a loss of about half the coding sequence, including the signal peptide for protein secretion. The mutation is kept on a C57BL/6 background. Pathway analysis Pathway analysis was conducted with the online tool "Pathway express", which is part of the "Onto-Tools", hosted by the Wayne State University, Detroit, USA, using the default options 26 . 
Gene ontology annotations
Quantitative reverse transcription-PCR
Quantitative RT-PCR was performed not only to investigate differential expression during development, but also to verify the microarray results. For p7, the same samples as in the array experiment were used. Generation of cDNA was accomplished as follows: 1250ng total RNA were reverse transcribed in a 20µl reaction, using random hexamers pd(n) 6 
Immunohistochemical staining and histology
Cryosections were prepared from male wt and Ndph y/-mice aged p3, p5, p7, p10, p15 and For retinal flatmounts, eyes were dissected and fixed for 15min in PBS/4% paraformaldehyde. Retinae were removed and post-fixed for additional 15min. After washing in PBS, unspecific binding was blocked by 10% normal sheep serum in PBST for 1h. Samples were then incubated o/n with the Collagen IV antibody. They were washed six times for 1h in PBST and incubated o/n with the secondary Cy3-labeled antibody. After repetition of the washing procedure, the retinae were finally flatmounted on microscope slides.
Sections (8µm) of paraffin-embedded eyes were hematoxylin-eosin stained as described elsewhere 15 and observed under bright-light illumination.
RESULTS
In this study, we used the Ndph knockout mouse to investigate molecular pathways involved in early angiogenic sprouting in the retina and the formation of deep retinal capillary networks at around postnatal day 7 (p7) 15 . We hypothesized that Norrin is required for these processes, probably by transcriptional regulation of Wnt/beta-catenin target genes and/or other pathways.
Retinal morphology at p7
At p7, conventional microscopy of HE stained retinal sections did not reveal apparent differences in the retinal morphology of wild type and Ndph knockout mice (Fig.1A, B 
Microarray gene expression analysis
To identify differently expressed genes in the retina of Ndph knockout mice, we took a global gene expression approach using microarrays. The gene chip experiment resulted in 26'817 expressed probe sets in p7 retinae. Differences in the overall expression levels between Ndph y/-and wild type retinae were rather moderate, both in absolute number and fold-change.
In microarray studies, usually an arbitrary fold-change cut-off of 2.0 has been applied 28 , still resulting in dozens or hundreds of differently expressed genes. Yet, expression changes of highly expressed genes may still be biologically relevant despite a fold-change lower than 2.0, while weakly expressed transcripts may show a fold-change higher than 2.0 due to their greater inherent measurement error 28 . In this study, we reasoned that a cut-off of 1.6 might still be valid considering our use of five biological replicates (instead of the standard three) while giving us a decent list of differently expressed genes.
The list of expressed probe sets was subjected to a non-parametric Mann-Whitney test with multiple testing correction (Benjamini-Hochberg, p<0.1). This resulted in a list of 450 probe sets (with 10% = 45 false positives), thirty-four of which showed a fold-change of at least 1.6.
Each of the thirty-four represents a different gene (Table 2) , including five currently unknown cDNAs. Sixteen transcripts show an elevated expression in the knockout, while levels of eighteen genes are decreased.
Since only one of these 34 genes (Apcdd1) has been associated with the Wnt-signaling pathway so far, we attempted to find evidence for its involvement with a pathway analysis.
Because the list of 34 genes was too small for this purpose, we subjected the list of expressed probe sets to a non-parametric Mann-Whitney test (p<0.01), but this time without multiple testing correction and fold-change cut-off. This resulted in a list of 872 probe sets (730 genes or ESTs) to be considered differently expressed between wild type and knockout. We then performed a pathway analysis based on these 730 genes by utilizing the online tool "Pathway express" 26 . Also here, an involvement of Wnt-signaling was not striking. The five most prominent affected pathways were: the MAP-Kinase pathway, focal adhesion, calciumsignaling, tight junction, and only then, Wnt-signaling (Table 3 ). Due to the low statistical power of this analysis, these results must be treated with caution. While they might provide clues for future research activities, they have to be verified first by independent experiments.
In the study presented here, we decided to concentrate on the list of the 34 most differently expressed genes ( Table 2) .
As expected for a knockout, the Ndph gene appears in the list of lower expressed genes.
However, its expression is only decreased by the factor of two. One possible explanation could be the general low retinal Ndph expression in the wild type, so the indicated foldchange could be the result of a measurement error. Second, the knockout is not a complete null-allele, but rather lacks most of exon 2, resulting in the loss of about half its coding 
Verification of differential expression by qRT-PCR
To validate the microarray results, qRT-PCR was performed for three of the most upregulated and six of the most downregulated transcripts using the same p7 retina RNA samples that were used for the array experiment. Relative quantification values were determined with 18S
or 28S rRNA and Gapdh (not shown) as endogenous controls. Expression values in general seemed to correlate with the microarray results (Fig. 2) . Five genes were proven to be significantly differently expressed. Three genes showed a decreased expression in the knockout: The neutral amino acid transporter Slc38a5 (24x less), apolipoprotein D (ApoD;
2.4x less) and angiotensin II receptor-like 1 (Agtrl1; 2x less). Increased expression was found for the plasmalemma vesicle-associated protein (Plvap; 4.2x higher) and adrenomedullin (Adm; 2.7x higher).
Despite the low fold-change threshold of 1.6 for our microarray statistical analysis, we were able to confirm differential expression of more than half the genes examined.
Expression during development
We further investigated expression for the two most differently expressed verified genes, Plvap and Slc38a5, during postnatal retinal development. In addition to p7, qRT-PCR was conducted on retinal cDNA from p5, p10, p15 and p21 (Fig. 3) .
Plvap expression in the knockout was significantly increased at every developmental stage in comparison to the wild type. The difference increased about one order of magnitude in later stages (p15/p21) when compared to the earlier stages (p5-p10) (Fig. 3A) .
Slc38a5 expression was significantly decreased at every developmental stage in the Ndph knockout (Fig. 3B) . Fold-change was about ten times lower at p5 and p15, about twenty-five times lower at p7 and p10 and about three times lower at p21. Since the Slc38a5 locus is located within 8.6 Mb from the Ndph locus, we investigated whether the observed difference was caused by a different genetic background, because the knockout Ndph allele is derived from the 129P2 mouse strain, which has then been backcrossed to the C57BL/6 background.
We could not exclude a background effect by analysis of a genetic marker inside the Slc38a5 locus (rs13483703), since it indicated the 129P2 allele at this position. Thus, we studied the expression of Slc38a5 by additional qRT-PCR on p7 retinae of 129P2 wild type males and found similar levels as in the C57BL/6 wild type group (data not shown). Consequently, we excluded an influence of the genetic background on the expressivity of Slc38a5.
In summary, these developmental studies, which were performed on array-experiment independent RNA samples, added additional proof to the obtained microarray gene expression data.
Immunohistological staining of Plvap
As gene expression differences do not always reflect consequences at the protein level, immunohistochemistry was also performed for Plvap at all developmental stages that have been investigated on the transcript level (plus p3 in addition). Eye cryosections of Ndph y/-and wild type mice were co-immunolabeled with antibodies directed against Plvap, a high specific marker for endothelial cells (MECA-32) 30 , and collagen type IV (ColIV) to visualize the vascular beds 23 ( Figure 4) . In all stages investigated (p3-p21), ColIV staining has been observed in the choroid and the superficial retinal vasculature of both genotypes. Vessels of the inner retina, located in the outer and inner plexiform layers, were detected in later stages in the wild type, but not the knockout retina, as has been described before 13, 15 .
Plvap was localized similarly to the choroidal vessel system in both wild type and knockout animals at all investigated developmental stages. However, the Plvap staining pattern of the retinal vasculature differed considerably. In the wild type, labeling was very faint at most.
Differential gene expression in Ndph knockout mice in retinal development 15
Traces were observed in the superficial network at p3, but not in later stages, and the deep vessel system appeared to be slightly stained only at p10 (Figure 4, arrows) . In contrast, Plvap staining in the knockout was detected as early as p3, but even more obvious and with increasing intensity at all later stages.
Taken together, these data show that Plvap expression in Ndph y/-retinae is increased not only on transcript, but also on protein level, which in particular seems to be confined to the retinal vasculature.
DISCUSSION
Norrin and the role of Wnt-signaling
When Norrin has been shown to bind to the Wnt-receptors Frizzled-4 and LRP-5 23 , it was suggested that signaling occurs through the canonical Wnt/beta-catenin pathway.
Surprisingly, our study suggested only one gene among the most differently transcribed genes besides Ndph to be associated with this pathway: Adenomatosis polyposis coli downregulated 1 (Apcdd1). This does not necessarily mean that Norrin is not exerting its function over binding to Wnt-receptors -but it may imply that Norrin does not work primarily as a transcriptional regulator via the canonical Wnt/beta-catenin signaling. However, this conclusion relies heavily on the number of currently known Wnt target genes, and on the assumption that this signaling actually occurs in p7 retinae -so it is still possible that this pathway is more prominent at another developmental stage. Furthermore, since we were not able to detect expression differences of two major angiogenesis-related genes albeit they have been shown to be regulated by Wnt-signaling (Tie-2/Tek 31 and Vegfa
32
), it is possible that Norrin has a direct role in controlling expression of Wnt-target genes in a spatially and temporally restricted manner which was not detectable by our experimental approach.
On the other hand, we were able to confirm differential expression of five genes that so far
were not shown to be Wnt-targets.
Plvap as an early indicator for vascular permeability
Our results suggest an early involvement of Plvap (plasmalemma vesicle-associated protein)
in the pathogenesis of NDP-related retinopathies. We found increased mRNA expression of Plvap throughout development (Fig. 3A) and also conclusive differences between immunostained cryosections of wild type and Ndph y/-mice ( Figure 4) . Plvap is endothelial cell specific, and has been described as integral membrane glycoprotein associated with the stomatal diaphragms of caveolae, transendothelial channels, vesiculo-vacuolar organelles and the diaphragms of endothelial fenestrae 24, 33 . Enhanced prevalence of endothelial fenestrae might result in reduced vascular integrity. Both have been observed in retinae of Ndph y/-mice as soon as p14 13, 15 . Plvap expression further has been shown to be negatively correlated with the differentiation of the blood-brain-barrier 30 . Hence, elevated expression of Plvap may indicate enhanced vascular permeability and break-down of the blood-retina-barrier. It has previously been proposed that blood vessel leakiness is a result of hypoxia-driven VEGF (vascular endothelial growth factor A) upregulation 15 and thus is a secondary effect due to low oxygen supply. Interestingly, Plvap itself has been suggested to be a VEGF target 34 , rendering a correlation between vessel leakiness and Plvap more likely. Thus, elevated expression of Plvap in later developmental stages (p15 onwards; Fig. 3A, 4) , when a malformed/underdeveloped vasculature causes a pathologic hypoxic condition in the retina, was not surprising. Development of the superficial vessel system, however, is driven by a physiological hypoxia through induction of a periphery-to-center gradient of VEGF 14 .
Noteworthy, this hypoxia-driven VEGF expression does not, or only marginally, yield visible Plvap expression in the wild type situation that is detectable by immunohistochemistry.
Therefore, we think that an increased Plvap expression in early developmental stages (p3-p10; Fig. 3A, 4) of Ndph y/-mice is not secondary due to low oxygen supply and subsequent VEGF upregulation, but rather due to a lack of Norrin that may have an important influence on vascular development. This is supported by the observation that Plvap upregulation is not solely dependent on hypoxia or VEGF, but is also triggered by other activation of the Erk1/2 MAPK pathway 35 . In addition, also fenestrae induction has been shown to be VEGFindependent, as it is regulated through cytoskeletal remodeling by actin depolymerization 36 .
However, we could not detect differences in total-and phosphorylated ERK1/2 MAP-kinase levels on Western blots with retinal protein extracts from p7 Ndph y/-wild type and knockout animals so far (data not shown). Additionally, differences in Plvap expression may be due to a mechanism of endothelial cells to compensate the impaired blood vessel development, because evidence has been provided before that Plvap might have a role in angiogenesis 37 .
Thus, it remains to be shown whether a possible mode of action for Norrin, besides transcriptional regulation via the Wnt/β-catenin pathway, might be a direct modulation of the microtubule cytoskeleton 38 or Plvap itself. While we are aware of these alternatives, we 
Differential gene expression reflects impaired blood vessel development
Besides Plvap, we were able to confirm differential expression of four more genes. All but one of them seem to emphasize Norrin's hypothetical role in blood vessel development. Nevertheless, ApoD could be implicated in the observed angiogenic defect of Ndph y/-mice, because it has been reported to stimulate proliferation and migration of vascular smooth muscle cells 41 , probably through modulation of the cellular response to Pdgf-bb 42 . ApoD expression was suggested to be induced by PDGF-BB itself 43 . Interestingly, Pdgfb and Pdgfrb expression have been shown to be decreased in Ndph y/-mice in early stages (p5/p10) before 15 ,
which could indicate reduced angiogenic activity. Although Pdgfb has been shown to be regulated by VEGF 43 , Vegfa levels were not different at p5 and even higher at p10 15 ,
suggesting an alternative, VEGF-independent transcriptional regulation of Pdgfb, and thus ApoD, in Ndph knockout mice. The possibility of a functional relationship between Norrin and ApoD might be supported by the finding of co-expression of these two genes in diseaseaffected organs. APOD has been shown to be upregulated in human endometrium during implantation 44 , a process that is disturbed in female homozygous Norrin knockout mice 45 .
Further, ApoD expression was also reported in the inner ear, another affected organ in Norrie disease patients and mice 46 , where it has been suggested to be implicated in cochlear fluid homeostasis 47 . Taken together, Norrin may influence angiogenesis either by direct transcriptional regulation of ApoD, or indirectly via Vegfa-independent regulation of Pdgf-β.
Nearly three times elevated transcript levels in the knockout were observed for adrenomedullin (Adm) by quantitative RT-PCR. It has been described to be a hypoxia induced vasodilating peptide 48 that might have a vascular protective function 49 . Adm probably exerts its protective role through a reduction of oxidative stress 50 and has further been shown to inhibit vascular remodeling 51 . It is tempting to speculate that elevated expression of Adm itself could lead to a developmental defect due to its anti-angiogenic properties, and that improper transcriptional regulation might be the cause for it. Hence, also differential expression of Adm correlates well with the Ndph y/-phenotype.
Surprisingly, and in contrast to the other genes discussed here, the gene most differently expressed has not directly been linked to angiogenesis. Slc38a5 (solute carrier familiy 38, member 5), which showed a twenty-five times decreased expression at p7 in Ndph y/-mice (Fig. 3B) , has been reported to be a main glutamine transporter in retinal Müller cells (system N2) 52 . It therefore may play an important role for the neuronal signal transduction through regulation of the glutamate/glutamine household. Its decreased expression in Ndph y/-mice may indicate an involvement of Müller glia cells as a target of Norrin signaling. This may be reflected by the reduced synaptic activity that has been observed by ERG measurements in later stages 53 and is consistent with our observation that Slc38a5 expression is decreased at every developmental stage investigated, including the rather mature p21 (Fig. 3B) . Besides their importance for neural function, Müller cells also play a role as guidance structures for the developing deep retinal vasculature 14 . As such, one could speculate that communication between Müller cells and blood vessels might be disturbed in Norrin knockout mice.
Interestingly, it has been reported earlier that blood vessels of the ganglion cell layer are frequently not surrounded by glia in p14 Ndph y/-mice 13 . However, another possible explanation for reduced Slc38a5 expression could be a secondary, neuroprotective response of Müller cells to oxidative stress. While this seems to be a likely mechanism at later, hypoxic stages in development (p15/p21), we think a ten-fold decreased expression of Slc38a5 at p5 is unlikely to be exclusively the result of hypoxia-induced neuroprotection (Fig. 3B ). Besides this, no evidence for hypoxia at p5 has been provided so far: Western blots for the glial stress marker GFAP and the hypoxia-inducible factor 1-alpha (Hif1a) were shown to be similar up to p15 and p10, respectively, and no significant expression differences could be found for VEGF 15 at this stage. But Slc38a5 is not only expressed in the retina: it is also abundant in astrocytic end feet in the brain, the highest levels being found in neocortex, hippocampus, striatum and the cerebellum 54 .
Thus, differential expression of this molecule might be a hint for a possible pathogenic mechanism also in the brain that could be associated with the mental retardation phenotype of ND. Noteworthy in this context, a microdeletion including SLC38A5 and the neighboring FTSJ1 has been found in three brothers with moderate to severe mental retardation 55 .
Conclusion
Consistent with data obtained from other developmental stages 15 , our examination of p7 Ndph knockout mice showed insufficient retinal capillarization and lack of deep vessel formation.
For the first time, vascular permeability has not been observed only in later, nearly adult stages, but was noted throughout development, as indicated by elevated mRNA and protein expression data for Plvap.
Because of the early developmental stage investigated here and the lack of neovascularization in later stages, we tend to consider a role of VEGF itself in the early pathogenesis of NDPrelated diseases rather unlikely and ask whether Norrin instead might modulate the cellular response to VEGF. Norrin's hypothetical role as a transcriptional regulator of Wnt/β-catenin target genes is not obvious from the array experiment. However, our recent and previous studies suggest that Norrin is important for retinal angiogenesis. Here, we could identify several genes probably implicated in blood vessel development that may be transcriptionally regulated by Norrin, directly or indirectly. These genes include Agtrl1, ApoD, and Adm, while Slc38a5 might represent an interesting candidate with regard to future research of aberrant neuronal development and the massive reactive gliosis that may be the basis for the often described pseudogliomas in ND patients 56 . Finally, due its proposed role in angiogenesis and blood vessel integrity 24, 37 , our findings suggest an important contribution of Plvap to the pathogenesis of Norrin-associated diseases. 
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Mdm2
Transformed (wt or ko) and then subjected to a non-parametric test for differential expression (Mann-Whitney test with Benjamini-Hochberg multiple testing correction, p<0.1). This resulted in 26'817 probe sets to be considered expressed, of which 450 were identified to be differentially expressed (with an error rate of 10%). 34 genes showed a fold-change of at least 1.6. GO terms listed may not include all annotations for each gene, but rather only parent or main annotations to facilitate a first impression of possible gene function.
Verification of array results
Figure 2
Transcriptional analysis of selected genes in retinae of Ndph y/-knockout (n=5) and wild type (n=5) mice. The average expression value of the wild type group was set to 1. Error bars indicate the confidence interval at a significance level of 95% (p<0.05). Quantitative RT-PCR results from p7 retinae for genes that showed increased or decreased expression in the array experiment are depicted in (A) or (B), respectively. (A) Expression of Adrenomedullin (Adm; 2.7x) and the gene for the Plasmalemma vesicle associated protein (Plvap; 4.2x) is significantly increased at p7. (B) The neutral amino acid transporter Slc38a5 (25x), Apolipoprotein D (ApoD; 2.4x) and Angiotensin II receptor-like 1 (Agtrl1; 2x) show significantly decreased expression at p7. Significant difference in Claudin 5 (Cldn5) expression is borderline. 18S / 28S rRNA were used as endogenous controls. Figure 3 Transcriptional analysis of the two most differently expressed verified genes in retinae of Ndph y/-knockout (n=5) and wild type (n=5) mice. The average expression value of the wild type group was set to 1. Error bars indicate the confidence interval at a significance level of 95% (p<0.05). (A) Plvap expression is significantly increased at every developmental stage from p5 to p21. Difference between wild type and knockout increases about one order of magnitude in later stages (p15/p21) when compared to the earlier stages (p5-p10). Insert shows expression data for p5-p10 in a different scale. (B) Slc38a5 expression is significantly decreased at every developmental stage. Variability of wild type expression is higher in later stages (p10-p21) than in early stages (p5, p7). Following endogenous controls were used: (A): 18S rRNA (B): Gapd Figure 4 Immunofluorescence images of retinal cryosections of Ndph y/-mice in comparison to wild type. For each one of the indicated developmental stages (p3, p5, p7, p10, p15 and p21), co-immunolabeling with antibodies directed against Plvap (AF488; green) and Collagen-IV (Cy3; red) has been performed. Collagen-IV localizes to the extracellular matrix of endothelial cells and serves as a marker for blood vessels. In all stages investigated, staining has been observed in the choroid (CV, below the RPE) and the superficial retinal vasculature (RV, inside the RGC/nerve fibre layer). From p10 onwards, blood vessels of the secondary, deep retinal vasculature were detected in the OPL in the wild type, but not the knockout retina. In addition, at p15 and p21, the tertiary, intermediate vessel system in the IPL can be seen in the wild type. Plvap localizes to the choroid vessel system (CV) in both wild type and knockout at all developmental stages. Interestingly, Plvap expression has also been detected in the retinal vasculature (RV) of the knockout animals beginning at p3 and more intense over time. In contrast, the retinal vasculature of the wild type is not, or only very weakly, labeled by the Plvap antibody. In the superficial vessel network, staining in the wild type could only be detected at p3 (arrow), but not in later stages. At p10, slight staining of the deep vessel system was observed (arrows). RV: superficial / deep retinal vasculature; CV: Choroid; RGC: retinal ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear layer; RPE: retinal pigment epithelium. Table 3 Results of a pathway analysis performed with the online tool "Pathway express", which is part of the "Onto-Tools", hosted by the Wayne State University, Detroit, USA 26 . Only 10% of the input genes could be mapped to a pathway based on the KEGG Pathway Database.
Relative expression in development
